17β-estradiol / levonorgestrel transdermal patch for hormone replacement therapy

摘要

The present invention relates to a method for reducing triglyceride levels in a patient and effecting hormone replacement therapy comprising continuously and transdermally administering an essentially constant therapeutically effective amount of a composition comprising an estradiol (17beta-estradiol) and a progestin (levonorgestrel (LNG)) in a pharmaceutically acceptable carrier.